Lexology January 14, 2025
Life sciences licensing partner Amanda Austin moderated Ropes & Gray’s annual “From the Boardroom” panel – held in San Francisco during the 2025 J.P. Morgan Healthcare Conference – which this year looked at how companies can use deals structured as an option to obtain an exclusive license or acquisition rights to pursue valuable collaborations and pipeline opportunities while achieving balance sheet objectives.
The panel – which featured Casarine Chong, Senior Vice President, Deputy General Counsel, Transactions, Bristol Myers Squibb, Chris Frankenfield, Chief Financial Officer and Chief Operating Officer, Xilio Therapeutics, John Mayfield, Senior Vice President of Business Development & Strategy, Flagship Pioneering, and Siobhan Pomeroy, Vice President, Corporate Development, Gilead Sciences, raised a number of points that will be of...